Dicronis GmbH develops microneedles for diagnostic and therapeutic purposes. The first product in our pipeline, Lymphit, measures patient’s lymphatic function in a safe, home-based and highly-scalable manner. The initial indication of Lymphit is the earliest possible diagnosis of secondary lymphedema, a serious side effect of many cancer therapies. By monitoring the lymphatic function, the physician is enabled for the first time to perform an early diagnosis, before the swelling has occurred, and evaluate the best conservative treatment for the patient. This leads to a great improvement of the prognosis and quality-of-life of the patient and important savings for the healthcare system and society.
Company Details
- Founded
- -
- Address
- Otto-Stern-Weg 7, Zurich,(Zh) 8093,switzerland
- in****@****nis.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- dicronis.com
- HQ
- Zurich, (ZH)
Dicronis Gmbh Questions
Dicronis Gmbh's website is dicronis.com
Dicronis Gmbh's LinkedIn profile is https://ch.linkedin.com/company/dicronis
Dicronis Gmbh's industry is
Pharmaceutical Manufacturing
Dicronis Gmbh's top competitors are
Pmi Switzerland,
Dr. Budliger Institut Für Gartentherapie,
Incircular,
Kägi Söhne Ag,
Creadd Ventures,
Uav-Zhcet,
Wetalkwithyou Ag,
Hypefy,
Expeerly,
Ascilion.
Dicronis Gmbh's support email address is info@dicronis.com
Dicronis Gmbh's categories are Pharmaceutical Manufacturing
Dicronis Gmbh's founding year is 2018
